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INTRODUCTION
Olfactory impairment is one of the most common diseases of
the sense organs and it is closely related to the quality of life,
yet the importance of a sense of smell is frequently ignored dur-
ing daily life (1, 2). The molecular mechanism of olfaction was
quite recently brought to light and a Nobel Prize was awarded
for this work (3). However, the pathogenic mechanism of olfac-
tory impairment is still unclear, and so its treatment is challeng-
ing. Olfactory impairment can be caused by degeneration of
olfactory receptor neurons in the nose and also by degeneration
of the olfactory bulb or olfactory cortex (4).
The main etiologies of olfactory loss include sinonasal inflam-
mation, viral infection of the upper respiratory tract and head trau-
ma. All of the etiologies cause death of olfactory receptor neurons
by different mechanisms. Throughout the whole life, olfactory recep-
tor neurons are regularly regenerated from neural stem cells in the
olfactory neuroepithelium (5). However, when regeneration fails,
the subject will suffer from permanent olfactory impairment.
The cells of the basal layer in the olfactory neuroepithelium are
regarded as neural stem cells and their injury may result in olfac-
tory dysfunction (6). Theoretically, restoration of the number of
neural stem cells in the olfactory neuroepithelium or their func-
tion might be a good target for treating olfactory loss, but there
Objectives. Treating olfactory dysfunction is a challenge for physicians. One of the therapeutic options could be trans-
plantation of stem cells. In this study, neural stem cells were transplanted into anosmic mice.      
Methods. Neural stem cells were generated from the olfactory bulb of green fluorescent protein (GFP)-transgenic
C57BL6 mice. Anosmia were induced by injection of intraperitoneal 3-methylindole. The neural stem cells were
transplanted transnasally on the next day. The olfactory function was evaluated by a food-finding test once a week.
The olfactory neuroepithelium was harvested for histologic examination and protein analysis at 4 weeks.
Results. Twenty-five percent (6/24) of the control mice that were not transplanted with neural stem cells survived at 4
weeks while 67% (8/12) of the transplanted mice survived (P=0.029). The food finding test showed that the trans-
planted mice resumed finding food at 3 weeks while the control mice resumed finding food at 4 weeks. GFP-positive
cells were observed in the olfactory neuroepithelium of the transplanted mice. Western blotting revealed that the
olfactory marker protein expression was significantly lower in the control mice than that in the transplanted mice. 
Conclusion. This study demonstrated that improvement of mouse survival was achieved and recovery of olfactory func-
tion was promoted by transnasal transplantation of neural stem cells in the anosmic mouse model. These results
indicate that stem cells might be one of the future modalities for treating olfactory impairment.
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investigated as a new treatment method for various diseases such
as myocardial infarction and stroke (7, 8). Cell-based therapy
might be a promising option even for olfactory impairment.
This study is aimed at investigating the efficacy of using neural
stem cells for olfactory recovery in an anosmic mouse model. 
MATERIALS AND METHODS
Preparation of neural stem cells
Neural stem cells were prepared from the olfactory bulb of green
fluorescent protein (GFP)-transgenic C57BL6 mice as previously
described (9). All the experiments were performed with the approval
of the Animal Care and Use Committee of Seoul National
University Bundang Hospital. The olfactory bulbs were dissected
out from the brain and mechanically dissociated by mincing.
Enzymatic dissociation of the cells in the olfactory bulbs was per-
formed by incubating the minced tissues in 0.25% trypsin
(Sigma, St Louis, MO, USA) for 10 min at 37℃. Thereafter, the
tissues were gently triturated and washed in Hank’s balanced salt
solution (Invitrogen, San Diego, CA, USA). The dissociated cells
were filtered through 40 mm nylon mesh (Millipore, Billerica,
MA, USA) to make a suspension of single cells. After washing,
the pellet of single cells was resuspended in DMEM/F-12 culture
medium (Invitrogen) supplemented with N-2 (R&D Systems,
Minneapolis, MN, USA), 20 ng/mL epidermal growth factor
(EGF, R&D Systems), 20 ng/mL basic fibroblast growth factor
(bFGF, R&D Systems) and penicillin/streptomycin (Sigma). The
cells were plated onto a 12-well plastic plate (Nunc, Rochester,
NY, USA) and maintained at 37℃ in 5% CO2. The cells were
immunostained with anti-nestin antibody (Chemicon, Temecula,
CA, USA) to identify their characteristics as neural stem cells.
Olfactory assessment
The olfactory ability of the mice was evaluated by a food-find-
ing test. All the mice were acclimated to the animal laboratory
environment for two weeks. During the acclimation period, the
mice were regularly fed a piece of cheese once a day. Before the
food-finding test, the mice were deprived of all the food, except
water, for 72 hr and then one mouse was placed in a cage to find
the piece of cheese buried beneath the wood shavings. The test
was performed four times every 15 min. The mouse was left in
the cage to find the cheese for up to 2 min. All the examined mice
found the cheese within 15 sec before induction of anosmia.
Induction of anosmia and transplantation of neural stem
cells
Anosmia was induced in thirty-six 6-week-old female C57BL6
mice by intraperitoneal injection of 3-methylindole (6,000 mg/mouse).
On the next day, 500,000 neural stem cells suspended in 50 mL
of culture media were transnasally transplanted in twelve mice.
Ten microliter micropipette tips were used for intranasal trans-
plantation. Five microliters at a time were alternatively admin-
istered on each side to prevent asphyxia due to aspiration. The
same amount of simple culture media was administered in the
other twenty-four mice as controls. The olfactory ability test was
performed every week and the mice were sacrificed at 4 weeks
after injection of 3-methylindole. The olfactory neuroepithelium
was obtained for histologic examination or immunoblotting.  
Whole tissue mounting
To confirm the presence of transplanted neural stem cells in the
olfactory neuroepithelium without any staining process, the whole
olfactory neuroepithelium was microscopically dissected after
bisection of the head and the olfactory neuroepithelium was
elevated from the underlining ethmoturbinate of the transplant-
ed mice 4 weeks after transplantation. The whole tissue was mount-
ed on slides and the green fluorescence, which represents trans-
planted neural stem cells, was observed. 
Immunohistochemistry
Immunohistochemistry and Western blot assay were performed
as previously described. Briefly, for immunohistochemical stain-
ing, the heads of the mice, including the olfactory neuroepitheli-
um, were fixed in 4% paraformaldehyde (Sigma) overnight.
Thereafter, the head was decalcified with Decalcifier (National
Diagnostics, Atlanta, GA, USA) at room temperature (RT) for
5 hr and then it was rinsed with distilled water for 15 min four
times. Cryoprotection of the specimens was performed using
sucrose in phosphate buffered saline (PBS). The specimens were
serially placed in 10% sucrose for 1 hr, in 20% sucrose for 1 hr
and finally in 30% sucrose overnight in a cold room. The speci-
mens were embedded in ornithine carbamyl transferase com-
pound and stored at -20℃. The frozen specimens were cut 5
mm in thickness and these sections were immediately mounted
on slides. Immunohistochemistry was performed using an Ultravision
Immunohistochemistry detection kit (Lab Vision, Fremont, CA,
USA).
For staining the olfactory marker protein (OMP), the sections
were incubated with goat anti-OMP (1:10,000; Wako Pure
Chemicals, Osaka, Japan) at 4℃ overnight. Biotinylated rabbit
anti-goat IgG (Zymed, San Francisco, CA, USA) was then applied
and incubated at RT for 10 min. For visualization, the sections
were incubated with horseradish peroxidase-conjugated strep-
tavidin at RT for 10 min. For contrast, the sections were also
stained with hematoxylin.
Since the green fluroscence was quenched with the staining
process, the GFP was stained with an antibody against GFP. The
staining for GFP was performed on a section just adjacent to the
section stained for OMP. The section was incubated with rabbit
anti-GFP (1:1,000; Novus Biologicals, Littleton, CO, USA) at 4℃
overnight, and biotinylated goat anti-rabbit IgG (Labvision) was
then applied and incubated at RT for 10 min. The control stain-
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ing was performed on sections from a GFP-transgenic mouse
and a normal mouse.
Immunoblotting
The OMP levels were examined by immunoblotting 4 weeks
after transplanting the neural stem cells. Olfactory neuroepithe-
lium were collected for immunoblotting. After the mice were
sacrificed, the ethmoturbinate was removed, the olfactory neu-
roepitheium was microdissected under a microsurgical micro-
scope and then it was quickly placed in a liquid nitrogen tank.
The microdissected olfactory neuroepithelium was homoge-
nized and the protein was extracted using protein extraction
buffer (Intron, Seoul, Korea).
The olfactory neuroepithelium samples were subjected to 15%
SDS-PAGE and the proteins were transferred to a polyvinylidene
fluoride membrane. The reliability of sample loading and elec-
troblotting in each experiment was evaluated by staining nitro-
cellulose membranes with Ponceau S (Bio-Rad, Hercules, CA,
USA) before immunoblotting. If the transfer was not uniform,
then the blots were discarded and the gels were run again. The
blots were blocked with 5% nonfat dry milk with 0.1% Tween
20 in 50 mM Tris-buffered saline (pH 7.4) and incubated overnight
at 4℃ with a goat anti-OMP antibody. After the primary anti-
body incubation, the blots were washed and incubated with horse-
radish peroxidase-conjugated donkey anti-goat IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA). Thereafter,
the blots were developed with enhanced chemiluminescence
(Amersham, Arlington Heights, IL, USA) and exposed to x-ray
film. The blots were then reprobed with an antibody to a-tubu-
lin (Labfrontier, Seoul, Korea) as a control for protein loading.
The signal intensity of Western blotting was quantified by den-
sitometry using the Bio-image analyzer (Vilber Lournat, Cedex,
France) and it was normalized to the corresponding signal for
a-tubulin. The relative density of the OMP protein band com-
pared to that of a-tubulin was calculated.
Statistical analysis
The Kaplan-Meier method was used to estimate the probability
of survival, with death being the event of interest. The non-para-
metric log-rank test was employed to compare the survival curves.
The time spent until the food was found, as well as the relative
densities of OMP on the western blotting, was compared by
student’s t-test. P-values less than 0.05 for the statistical tests
were considered statistically significant. 
RESULTS
Identification of neural stem cells
The cultured olfactory bulb-derived cells formed neurospheres
and they were successfully were passaged. The cells showed green
fluorescence since the cells originated from GFP-transgenic mice
(Fig. 1A). Immunostaining of the neurospheres with nestin, which
is a neural stem cell marker, showed that the neurosphere-form-
ing cells were neural stem cells (Fig. 1B). 
Promotion of survival and olfaction
Twenty-five percent (6/24) of the control mice that were not trans-
planted with neural stem cells survived at 4 weeks after injection
of 3-methylindole. On the other hand, it is quite interesting that
67% (8/12) of the transplanted mice survived at 4 weeks (P=0.029)
(Fig. 2). During the 4 weeks, the transplanted mice have looked
healthier than the control mice. 
The olfactory function of the mice was evaluated by the food
finding test. Five out of six transplant mice could find the food
at 3 weeks while two out of six control mice could find the food
Fig. 1. Neurospheres from the olfactory bulb of the green fluorescence protein-transgenic C57BL6 mice (A). The neural stem cells have formed
neurospheres floating in the culture media. Immunoreactivity to a marker for neural stem cells (B). The neurosphere-forming cells were
immunoreactive to nestin (red), which is a neural stem cell marker.
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at 3 weeks (Fig. 3). At 3 weeks, the time spent to find the food
was 105±25 sec for the control mice and it was 74±34 sec in
the transplanted mice (P=0.13). At 4 weeks, the time spent to
find the food was 79±29 sec for the control mice whereas it
was 42±20 sec for the transplanted mice (P=0.04).
Histological and molecular assessment 
The whole tissue mounting of the olfactory neuroepithelium on
the slides demonstrated several conglomerates of green fluores-
cent neural stem cells that had been transplanted and they resided
in the olfactory neuroepithelium (Fig. 4). 
OMP-positive or GFP-positive cells were observed on the
immunohistochemical staining of the consecutive sections of the
olfactory turbinates. OMP-positive cells were observed in the
olfactory neuroepithelium from the healthy wild-type mice that
were not treated with 3-mehtylindole and that had normal
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Fig. 3. The olfactory function. The olfactory function was evaluated by the time spent to find a piece of cheese buried beneath the wood shav-
ings. Five out of six transplanted mice (right) with neural stem cells (NSC) could find the food at 3 weeks while two out of six control mice could
find the food at 3 weeks (left). At 3 weeks, there was no significant difference in the time spent to find the cheese between the control and
transplanted mice (P=0.13). On the other hand, at 4 weeks, the cheese was found more quickly by the transplanted mice than by the control
mice (P=0.04). NSC (-) denotes without transplantation of NSC while NSC (+) with transplantation.
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Fig. 2. The survival analysis. Six out of twenty-four control mice that
were not transplanted with neural stem cells (NSC) survived at 4
weeks after injection of 3-methylindole, while 8 out of the 12 trans-
planted mice survived at 4 weeks (P=0.029).
Fig. 4. Neural stem cells in the whole-mount olfactory neuroepitheli-
um. The whole tissue mounting showed several conglomerates of
green fluorescent neural stem cells that had been transplanted and
they resided in the olfactory neuroepithlium.88 Clinical and Experimental Otorhinolaryngology  Vol. 3, No. 2: 84-90, June 2010
olfactory function, but there were no GFP-positive cells (Fig.
5A, 5B). In the olfactory neuroepithelium from the anosmic
mice that were not transplanted with neural stem cells, there were
no OMP- or GFP-positive cells (Fig. 5C, 5D). In the transplanted
mice, there were no GFP-positive cells in some of the olfactory
neuroepithelial regions (Fig. 5E, 5F), while cells positive for both
OMP and GFP were observed in some regions (Fig. 5G, 5H). 
Western immunoblotting of the olfactory neuroepithelium
showed a significant difference of the OMP expression between
the control and transplanted mice (Fig. 6). The expression of
OMP was significantly higher in the transplanted mice than that
in the control mice.
DISCUSSION
Transplantation of stem cells has been suggested to be one of
the innovative future treatment modalities for various untreat-
able diseases (10). One of the target diseases is neurodegenera-
tive diseases such as Parkinson’s disease (11-13) and Alzheimer’s
disease (14, 15). Anosmia is also one of the neurodegenerative
diseases that cannot be treated by the current medical or surgi-
cal techniques. Olfactory receptor neurons are known to regen-
erate throughout the lifetime because there are some cells in
the basal layer of the epithelium that play a role as neural stem
cells. However, some patients suffer from permanent olfactory
Fig. 5. Immunohistochemical staining for olfactory marker protein (OMP) and green fluorescent protein (GFP). The staining was performed on
the consecutive sections of the olfactory turbinates. OMP-positive cells were observed (A) in the olfactory neuroepithelium from the healthy
wild-type mice that were not treated with 3-mehtylindole and that had normal olfactory function, while there were no GFP-positive cells (B).
There were no OMP- (C) or GFP-positive cells (D) in the olfactory neuroepithelium from the anosmic mice that were not transplanted with neural
stem cells. In the transplanted mice, the cells were only positive for OMP (E) but not for GFP (F) in some olfactory neuroepithelial regions,
whereas cells that were positive for both OMP (G) and GFP (H) were observed in some regions.
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Fig. 6. Western immunoblotting of the olfactory neuroepithelium. Olfactory marker
protein (OMP) was more highly expressed in the transplanted mice than that in the
control mice (A). Densitometric analysis showed a significant difference of the
OMP expression between the control and transplanted mice (B). neural stem cells
(NSC) (-) denotes without transplantation of neural stem cells while NSC (+) with
transplantation.
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Bloss in spite of the regenerative potential of the olfactory neu-
roepithelium, and this may be explained when there is a signifi-
cant reduction of the stem cell population in the epithelium.
There have been some previous trials to transplant stem cells
in the olfactory neuroepithelium. Human cord blood CD133-
positive stem cells were intravenously injected to nod-scid mice
and this was shown to provide conditions for regeneration of
the olfactory neuroepithelium after permanent damage was
induced by dichlobenil (16). Adipose tissue-derived stem cells
were also intravenously injected to rats after their olfactory
nerve was transected (17). However, the olfactory nerve transac-
tion model is less likely to be appropriate for stem cell research.
It is because when an efferent neural signal pathway from the
upper level of the olfactory nervous system is interrupted, it
finally leads to death of the lower level of cells and specifically
the olfactory neuronal cells that have differentiated from the
injected stem cells. A study using bone marrow cells of GFP
mice revealed that bone marrow cells can be engrafted in the
olfactory epithelium of the irradiated mice and then be differ-
entiated into olfactory neuronal cells (18).
As shown in the above-mentioned studies, most of the stem
cell transplantation trials were performed via a parenteral route
using mesenchymal tissue-derived stem cells. However, systemic
administration of stem cells has disadvantages. A large part of
the cells will be trapped in the lung and therefore cannot reach
the target tissue (olfactory neuroepithelium) (19). This means
that a large number of cells are required to achieve therapeutic
effects. Neural stem cells might have more benefits than mesenchy-
mal tissue-derived stem cells in that neural stem cells might be
more easily differentiated into olfactory receptor neurons because
both of them are from the same neural lineage. In order to over-
come those disadvantages, neural stem cells were used and adminis-
tered directly into the nasal cavity in our study. Generally, stem
cells are known to ‘home’ to the site of injury (20). The olfactory
neuroepithelium can be completely de-epithelialized by intra-
venous injection of 3-mehtylindole. Therefore, the injected neur-
al stem cells might directly reside in the olfactory neuroepitheli-
um without a massive loss of the cells in the lung.
Out study showed a very interesting finding in terms of the
survival of the mice. Transplantation of neural stem cells was
associated with prolongation of survival in the anosmic mice.
The transplanted mice survived significantly longer than the non-
transplanted mice. Because the sense of smell is much more impor-
tant for survival in mice than in humans, the anosmic mice may be
more subject to death than the mice with normal olfactory func-
tion. Better survival in the transplanted mice might suggest that
they have better recovery from the anosmic condition by trans-
plantation of neural stem cells than the nontransplanted mice.
These results were also supported by other data in our study.
Transplantation of neural stem cells was associated with better
recovery of olfactory function in terms of the food-finding test
and the expression of OMP. However, this study has a weakness
that the anosmic mice had acute olfactory injury instead of chron-
ic injury, and the latter is more common in the actual medical situ-
ation. Therefore, further studies are required to identify the ther-
apeutic role of stem cells in long-lasting olfactory injury.
This study demonstrated that improvement of mouse survival
was achieved and recovery of olfactory function was promoted
by transnasal transplantation of neural stem cells in the anosmic
mouse model. These results indicate that stem cells might be one
of the modalities for treating olfactory impairment in the future. 
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